CSX vs GILD · P/E 19, rev $14.09B vs P/E 18, rev $29.44B
CSX Corporation (CSX) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CSX and GILD stock pages for the full models.
Not investment advice.